SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $127,000 | -56.9% | 106,700 | +17.8% | 0.00% | -100.0% |
| Q4 2021 | $295,000 | -61.8% | 90,600 | -47.5% | 0.00% | -50.0% |
| Q3 2021 | $772,000 | -44.7% | 172,700 | -32.6% | 0.00% | -50.0% |
| Q2 2021 | $1,396,000 | -36.9% | 256,100 | -13.4% | 0.00% | -33.3% |
| Q1 2021 | $2,213,000 | -11.6% | 295,800 | +28.2% | 0.01% | -14.3% |
| Q4 2020 | $2,504,000 | +55.5% | 230,800 | +26.7% | 0.01% | +40.0% |
| Q3 2020 | $1,610,000 | -17.1% | 182,100 | -0.1% | 0.01% | -16.7% |
| Q2 2020 | $1,943,000 | +307.3% | 182,300 | +126.7% | 0.01% | +200.0% |
| Q1 2020 | $477,000 | -34.6% | 80,400 | -23.8% | 0.00% | 0.0% |
| Q4 2019 | $729,000 | +107.1% | 105,500 | +177.6% | 0.00% | +100.0% |
| Q2 2019 | $352,000 | -6.1% | 38,000 | -7.3% | 0.00% | 0.0% |
| Q1 2019 | $375,000 | +32.5% | 41,000 | -19.3% | 0.00% | 0.0% |
| Q4 2018 | $283,000 | -57.1% | 50,800 | -8.3% | 0.00% | -50.0% |
| Q3 2018 | $660,000 | -12.7% | 55,400 | -25.1% | 0.00% | 0.0% |
| Q2 2018 | $756,000 | +620.0% | 74,000 | +585.2% | 0.00% | – |
| Q4 2017 | $105,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |